Programme
Keynote 5
Use of "Extended Clearance Concept" in new drug discovery and development; application to a drug classification system and to a design of clinical studies
Wednesday 24 May 2017
08:00-09:00
Stockholmsmässan : K2
Yuichi Sugiyama, RIKEN Innovation Center, Japan
Co-chair: Annika Kyssä, Sweden